Medical & affiliate disclosure: CTX Stat provides educational laboratory information and is not a substitute for professional medical advice, diagnosis, or treatment. CTX Stat may receive compensation from some outbound provider links when an affiliate program is active; provider comparisons and rankings are based on consumer fit, effective cost, access, policies, and reputation—not commission.
Quick take: The G6PD blood test measures glucose-6-phosphate dehydrogenase activity in red blood cells. Low activity suggests G6PD deficiency, an inherited enzyme condition that can make red blood cells more vulnerable to breakdown after certain triggers, including some infections, fava beans, and specific medicines. The test is a routine blood draw for most adults and older children, usually requires no fasting, and is interpreted against the laboratory’s age- and sex-specific reference range. A normal result can be misleading if testing is done soon after a hemolytic episode or transfusion, so repeat testing may be needed when clinical suspicion remains.
What the G6PD blood test measures
A G6PD test blood test measures the activity, and sometimes the amount, of glucose-6-phosphate dehydrogenase in your red blood cells. G6PD is an enzyme that helps red blood cells handle oxidative stress. Red blood cells do not have the same repair tools as many other cells, so they depend heavily on this enzyme pathway to keep hemoglobin and the cell membrane stable.
When G6PD activity is too low, red blood cells may break down faster than the body can replace them. This process is called hemolysis. If enough red blood cells are destroyed, hemolytic anemia can develop. MedlinePlus describes G6PD deficiency as an inherited disorder that mainly affects red blood cells and can lead to hemolytic anemia after exposure to triggers such as infections, fava beans, some antibiotics, and antimalarial medicines (MedlinePlus G6PD test).
Most people with G6PD deficiency are not constantly sick. Many have no symptoms until a trigger causes oxidative stress. The test is therefore not just an anemia test; it is a risk-identification test that can help clinicians explain past episodes of jaundice or dark urine, evaluate newborn jaundice, or choose safer medications.
Why a clinician may order a G6PD blood test
A G6PD test is commonly ordered when symptoms or circumstances suggest red blood cell breakdown. It may also be ordered before certain medications that can be unsafe in people with G6PD deficiency.
| Reason for testing | Why it matters |
|---|---|
| Symptoms of hemolytic anemia | Fatigue, pale skin, shortness of breath, rapid heartbeat, jaundice, or dark urine can occur when red blood cells are breaking down. |
| Newborn jaundice | G6PD deficiency can contribute to significant or atypical hyperbilirubinemia in newborns. The American Academy of Pediatrics notes that severe or unusual jaundice should raise the possibility of G6PD deficiency (AAP hyperbilirubinemia guideline). |
| Family history or ancestry-associated risk | G6PD deficiency is more common in people with African, Mediterranean, Middle Eastern, or Asian ancestry, though it can occur in any population. |
| Before specific medicines | Some drugs can cause hemolysis in people with G6PD deficiency. CDC malaria guidance says quantitative G6PD testing is required before tafenoquine and should be done before primaquine use in relevant situations (CDC malaria treatment guidance). |
| Cancer or gout-related drug decisions | Rasburicase is contraindicated in G6PD deficiency; current DailyMed labeling says higher-risk patients should be screened before therapy (DailyMed rasburicase label). |
G6PD deficiency in plain language
G6PD deficiency is usually inherited through the X chromosome. Because males typically have one X chromosome, a disease-causing G6PD variant can more directly lead to low enzyme activity. Females have two X chromosomes, so they may be carriers with normal, borderline, or low activity depending on which X chromosome is active in their red blood cell precursors. This is why a female patient can have symptoms even when the family has been told the condition “only affects males.”
The clinical impact varies. Some people have only a mildly reduced enzyme level and never have a known episode. Others have acute hemolysis after an infection, fava bean exposure, or a medication. A smaller group has more severe chronic hemolysis. The World Health Organization reviewed G6PD variant classification in 2022 and emphasized that enzyme activity and clinical risk exist on a spectrum rather than as a simple yes-or-no category (WHO G6PD classification review).
Preparation: do you need to fast?
Most G6PD blood tests do not require fasting. MedlinePlus states that no special preparation is needed for a G6PD test (MedlinePlus). If your clinician orders additional tests at the same visit, such as a fasting glucose or lipid panel, those other tests may have separate instructions.
Before the blood draw, tell the ordering clinician or lab if you recently had a blood transfusion, a hemolytic episode, severe infection, or treatment for anemia. These details can affect interpretation. Also bring a medication and supplement list. Do not stop prescribed medications on your own just to take a G6PD test; medication decisions should be made with the clinician who prescribed them.
For adults and older children, the sample is usually collected from a vein in the arm. For newborns, a heel-stick sample may be used depending on the setting and the testing method. The blood draw itself usually takes only a few minutes, but turnaround time depends on the laboratory and whether the test is performed locally or sent to a reference lab.
Types of G6PD testing
| Test type | What it tells you | Best use | Important limitation |
|---|---|---|---|
| Quantitative G6PD enzyme activity | Measures enzyme activity in red blood cells and reports a numeric value | Most useful for diagnosis and medication decisions that require activity level | Can be falsely normal after hemolysis or transfusion |
| Qualitative or screening test | Classifies activity broadly, often as normal or deficient | Rapid screening in some settings | May miss intermediate deficiency, especially in heterozygous females |
| G6PD genetic testing | Looks for variants in the G6PD gene | Family counseling, unclear enzyme results, or selected medication decisions | A negative panel may not rule out all clinically relevant variants unless coverage is comprehensive |
| Related hemolysis labs | CBC, reticulocyte count, bilirubin, LDH, haptoglobin, and smear assess red blood cell breakdown | Evaluating current symptoms or severity | They do not by themselves diagnose G6PD deficiency |
Many reference labs use quantitative enzyme testing. For example, Labcorp lists a quantitative whole-blood G6PD test that includes a red blood cell count and reports a usual turnaround time of 2 to 4 days after specimen pickup (Labcorp test information). Mayo Clinic Laboratories also describes G6PD enzyme activity testing and highlights interpretation cautions after hemolytic events (Mayo Clinic Laboratories test catalog).
How G6PD results are interpreted
Your report will show a result and a reference range. The units vary by laboratory. Some labs report units per gram of hemoglobin, some report units per red blood cell count, and some provide percent activity compared with a normal reference population. Because methods and units differ, do not compare your number directly with someone else’s result from a different lab.
| Result pattern | General interpretation | Practical next step |
|---|---|---|
| Low G6PD activity | Consistent with G6PD deficiency | Discuss trigger avoidance, medication precautions, family implications, and whether related hemolysis labs are needed. |
| Borderline or intermediate activity | May occur in heterozygous females, recent hemolysis recovery, newborns, or mild variants | Ask whether repeat quantitative testing or genetic testing is appropriate for your situation. |
| Normal activity with low suspicion | G6PD deficiency is less likely, especially in a male patient tested when well | Clinician may look for other causes of anemia, jaundice, or symptoms. |
| Normal activity with strong suspicion | Could be a false-normal result if testing occurred after hemolysis, transfusion, or marked reticulocytosis | Repeat testing later may be recommended; Labcorp notes that re-evaluation around three months after hemolysis may be useful when false-negative results are suspected (Labcorp limitations). |
A low result does not predict exactly how severe every future reaction will be. Clinical risk depends on the variant, the degree of enzyme activity, age, sex, other health conditions, and the strength of a trigger. In newborns, interpretation is especially careful because G6PD levels can be higher in newborn red blood cells than adult red blood cells, and bilirubin risk is influenced by multiple factors.
Why a normal result can be misleading
The most important limitation is timing. During an acute hemolytic episode, the oldest and most enzyme-deficient red blood cells may be destroyed first. The remaining blood can be enriched with younger red blood cells and reticulocytes, which tend to have higher G6PD activity. Mayo Clinic Laboratories cautions that normal G6PD activity values may be measured for several weeks after hemolysis and that reticulocytosis can mask some cases (Mayo Clinic Laboratories cautions).
Recent transfusion can also confuse results because donor red blood cells may have normal enzyme activity. If you were tested during hospitalization, after a transfusion, or soon after an episode of dark urine and jaundice, ask whether the timing could affect the result. This does not mean the test is unreliable; it means the result must be interpreted in context.
Testing in females can also be more complex. A heterozygous female may have a mixture of normal and deficient red blood cells. A screening test may report normal even when a substantial portion of cells are vulnerable. For this reason, quantitative enzyme testing is generally more informative than a simple screen when the result will affect medication choice or family counseling.
What happens after an abnormal result?
If your G6PD activity is low, the next step is usually education and documentation. Ask your clinician for the specific result, the lab’s reference range, and whether your result is mild, intermediate, or clearly deficient. Keep a copy in your medical record and tell future clinicians, dentists, pharmacists, and emergency care teams that you have G6PD deficiency.
Medication review is especially important. Do not rely on a generic internet list alone because risk can depend on dose, route, illness severity, and whether safer alternatives are available. Medicines commonly discussed in relation to G6PD include primaquine, tafenoquine, dapsone, nitrofurantoin, rasburicase, methylene blue, and certain sulfonamides. Some drugs have clear contraindications in G6PD deficiency; others require case-by-case judgment.
If you currently have symptoms such as yellowing of the eyes or skin, tea-colored urine, severe fatigue, shortness of breath, fainting, or rapid heartbeat, contact a healthcare professional promptly. Severe hemolysis can require urgent evaluation, especially in newborns, people with heart or lung disease, and anyone with significant anemia symptoms.
Related tests that may be ordered with G6PD
A G6PD test tells whether enzyme activity is low, but it does not fully describe whether hemolysis is happening right now. Clinicians may add a complete blood count to measure hemoglobin and red blood cells, a reticulocyte count to see whether the bone marrow is responding, bilirubin to evaluate jaundice, lactate dehydrogenase and haptoglobin to assess hemolysis, and a peripheral blood smear to look for red blood cell changes. In newborns, bilirubin measurement and age-in-hours risk assessment are central to decision-making.
How much does a G6PD blood test cost?
Cost depends on how the test is ordered. If a clinician orders the test through insurance, your out-of-pocket cost depends on medical necessity rules, deductible status, copay, coinsurance, and whether the lab is in network. The amount billed to insurance may be very different from the patient responsibility.
Self-pay and direct-order options vary by state and lab network. For example, Request A Test lists a G6PD blood test option at $59 for one laboratory option and describes typical turnaround times ranging from 1 to 8 business days depending on the lab option (Request A Test G6PD page). Quest’s consumer testing site notes that Quest lab tests may have an additional physician service fee starting at $6 for provider oversight (Quest consumer test information). Jason Health states that its listed prices include the lab order and that there are no additional lab charges, while also noting its collection network is not available in New York, New Jersey, or Rhode Island (Jason Health ordering information). These examples illustrate why the meaningful comparison is the effective total cost: base test price plus required clinician/order fees, collection fees, state restrictions, and whether a red blood cell count is included.
For context, the Medicare Clinical Laboratory Fee Schedule is much lower than many retail cash prices because it represents a payer schedule, not a consumer storefront price. CMS publishes the Clinical Laboratory Fee Schedule files and explains that including a code or payment amount does not itself imply coverage (CMS CLFS files). The consumer price you see online also includes ordering infrastructure, provider review where required, lab network access, and administrative costs.
When to seek urgent care
Seek urgent medical attention for sudden yellowing of the eyes or skin, dark cola-colored urine, severe weakness, chest pain, fainting, shortness of breath at rest, confusion, or signs of dehydration. For newborns, call the baby’s clinician urgently for worsening jaundice, poor feeding, unusual sleepiness, high-pitched crying, fever, or any concern that jaundice is spreading or intensifying. G6PD deficiency is manageable, but acute hemolysis and severe neonatal hyperbilirubinemia require timely care.
FAQs
Is the G6PD blood test painful?
It is similar to other blood draws. You may feel a brief pinch and may have minor bruising. Newborn testing may use a heel stick.
Can I take the test while I feel well?
Yes, and testing while well is often preferable because recent hemolysis can make results look less deficient than they truly are. If you are being tested because of a medication decision, follow the timing requested by your clinician.
Does a low G6PD result mean I have anemia all the time?
No. Many people with G6PD deficiency have normal hemoglobin between episodes. The risk is episodic red blood cell breakdown after oxidative stress, although some severe variants can cause chronic hemolysis.
Can diet affect the result?
Ordinary meals usually do not affect the enzyme activity measurement. Fava beans do not make the lab value low; rather, they can trigger hemolysis in susceptible people. Avoidance advice should come from your clinician after diagnosis.
Should family members be tested?
Possibly. Because G6PD deficiency is inherited, testing may be relevant for siblings, children, or reproductive planning, especially if there is a history of newborn jaundice, hemolysis, or medication reactions. A clinician or genetic counselor can help decide who should be tested and which test type is most useful.
Is genetic testing better than the enzyme test?
Not always. The enzyme test directly measures red blood cell enzyme activity, which is often what clinicians need for immediate diagnosis and medication safety. Genetic testing can add value when enzyme results are borderline, when testing females with possible carrier status, or when a family wants variant-specific information.
Sources
- MedlinePlus: G6PD Test
- Labcorp: Glucose 6-Phosphate Dehydrogenase, Quantitative
- Mayo Clinic Laboratories: G6PD Enzyme Activity, Blood
- American Academy of Pediatrics: Management of Hyperbilirubinemia in the Newborn Infant
- CDC: Treatment of Uncomplicated Malaria
- DailyMed: Elitek (rasburicase) Prescribing Information
- World Health Organization: G6PD Classification Review
- CMS: Clinical Laboratory Fee Schedule Files
Educational note: This article is for general health education and is not a diagnosis or individualized medical advice. Test interpretation should be reviewed with a qualified healthcare professional who knows your symptoms, medications, medical history, and the laboratory method used.
